Logo

CombiMatrix Wins $5.9M Contract from Department of Defense

Mar 08, 2004

NEW YORK, March 8 (GenomeWeb News) - Acacia Research unit CombiMatrix has won a $5.9 million, two-year contract from the Department of Defense to develop microarray technology for the detection of biological weapons, the company said today.

 

Under the contract, which follows earlier funding from the DoD, CombiMatrix will develop an automated system for detecting potential biothreats, such as Bacillus anthracis, Yersinia pestis, and toxins.

 

CombiMatrix has already been collaborating with the U.S. Army Medial Research Institute of Infectious Disease since last year, under a Cooperative Research and Development Agreement, to integrate its technology into devices.

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.